Campos Dayse Pereira, Ribeiro Sayonara Rocha, Grinsztejn Beatriz, Veloso Valdiléa G, Valente Joaquim Gonçalves, Bastos Francisco Inácio, Morgado Mariza Gonçalves, Gadelha Angela Jourdan
Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
AIDS. 2005 Oct;19 Suppl 4:S22-6. doi: 10.1097/01.aids.0000191486.92285.1c.
Recent studies have shown substantial increases in the survival of AIDS patients in developed countries and in Brazil as a result of antiretroviral therapy (ART) and prophylaxis for opportunistic infections. This study compares survival rates using the Brazilian Ministry of Health 2004 and Centers for Disease Control and Prevention (CDC) 1993 case definitions in a large HIV/AIDS referral centre in Rio de Janeiro.
Survival after AIDS diagnosis was assessed in a clinic-based cohort of 1415 individuals using the Kaplan-Meier method and Cox proportional hazards models.
There were 393 (88%) deaths from AIDS-related causes and 52 (12%) from unrelated or unknown causes. A total of 205 patients (14%) were lost to follow-up and 765 patients (55%) remained alive until the end of the study. Three-quarters of patients (75%) were still alive 22 months [95% confidence interval (CI) 19-26] after the AIDS diagnosis according to the CDC case definition and 31 months (95% CI 26-36) according to the Ministry of Health case definition. Independent predictors of survival included AIDS defined by CD4 cell count and any use of highly active antiretroviral therapy, with either case definition, and initial stage of the case, with the Ministry of Health case definition.
Survival observed in this reference centre is comparable or longer than other international studies, although the choice of case definition criterion influenced findings. Adoption of the Ministry of Health case definition may enhance the ability to track the use of and outcomes from ART among AIDS patients.
近期研究表明,在发达国家以及巴西,由于抗逆转录病毒疗法(ART)和机会性感染预防措施的实施,艾滋病患者的生存率大幅提高。本研究在里约热内卢的一个大型艾滋病毒/艾滋病转诊中心,比较了使用巴西卫生部2004年病例定义和美国疾病控制与预防中心(CDC)1993年病例定义的生存率。
采用Kaplan-Meier方法和Cox比例风险模型,对一个基于诊所的1415名个体队列进行艾滋病诊断后的生存情况评估。
有393例(88%)死于艾滋病相关原因,52例(12%)死于无关或不明原因。共有205例患者(14%)失访,765例患者(55%)在研究结束时仍存活。根据CDC病例定义,四分之三的患者(75%)在艾滋病诊断后22个月[95%置信区间(CI)19 - 26]仍存活;根据卫生部病例定义,这一数字为31个月(95% CI 26 - 36)。生存的独立预测因素包括根据CD4细胞计数定义的艾滋病、使用任何高效抗逆转录病毒疗法(无论采用哪种病例定义)以及病例的初始阶段(采用卫生部病例定义时)。
尽管病例定义标准的选择会影响研究结果,但本转诊中心观察到的生存率与其他国际研究相当或更长。采用卫生部病例定义可能会提高追踪艾滋病患者抗逆转录病毒疗法使用情况和治疗结果的能力。